Literature DB >> 32898568

A combined proteomic and metabolomic analyses of the priming phase during rat liver regeneration.

Hui Yang1, Jianlin Guo1, Wei Jin1, Cuifang Chang1, Xueqiang Guo1, Cunshuan Xu2.   

Abstract

By comparing differentially abundant proteins and metabolites, the protein expression, metabolic changes and metabolic regulation mechanisms during the priming phase of liver regeneration (LR) were investigated. We combined proteomic analysis via isobaric tags for relative and absolute quantification (iTRAQ) with metabolomic analysis via nontargeted liquid chromatography-mass spectrometry (LC-MS). LC-MS was used to examine 29 energy metabolites expression alterations in targeted metabolomics. A total number of 441 differentially expressed proteins and 65 metabolites were identified. PSMB10, PSMB5, RCG_63409, PSME4 and PSMB7 were key node proteins, these proteins are involved in the proteasome pathway. The most strongly enriched transcription factor motif was TP63. These results point out a critical role of the proteasome pathway (defense mechanisms) and of TP63 (metabolic regulator) as the key transcription factor during the priming phase of LR. Metabolomic and metabolite analysis showed that profiling indicates upregulation of arginine biosynthesis and glycolysis as the main ATP-delivering pathway. Integrative proteomic and metabolomic analysis showed that biomolecular changes were primarily related to the neurological disease, cell death and survival and cell morphology. What's more, neurotransmitters may play an important role in the regulation of LR.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Energy metabolism; Metabolomic; Priming phase; Proteomic; Rat liver regeneration

Mesh:

Substances:

Year:  2020        PMID: 32898568     DOI: 10.1016/j.abb.2020.108567

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  1 in total

1.  PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma.

Authors:  Sijia Ge; Hua Huang; Wei Huang; Ran Ji; Jing Chen; Shuzhen Wu; Liyang Wang; Tianxin Huang; Yu Sheng; Haiou Yan; Cuihua Lu; Lin Ma
Journal:  Int J Gen Med       Date:  2022-01-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.